Versican modulates gap junction intercellular communication

Journal of Cellular Physiology

Volumn 211, Issue 1, 2007, Pages 213-219

  Sheng, Wang ^a,b   Dong, Haiheng ^a,c   Lee, Daniel Y ^a,b   Lu, Wei Yang ^a,c   Yang, Burton B ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; ISOPROTEIN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG; VERSICAN; VERSICAN V1;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL MEMBRANE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOPLASM; GAP JUNCTION; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ANIMALS; CELL COMMUNICATION; CHICKENS; CONNEXINS; EPITHELIAL CELLS; GAP JUNCTIONS; GENE SILENCING; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; TRANSFECTION; VERSICANS;

EID: 33847670523     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20921     Document Type: Article

References (34)

1. Abdelmohsen K, Gerber PA, von Montfort C, Sies H, Klotz LO. 2003. Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: Role of glutathione and tyrosine phosphatases. J Biol Chem 278:38360-38367.
2. Ai Z, Fischer A, Spray DC, Brown AM, Fishman GI. 2000. Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105:161-171.
3. Aspberg A, Miura R, Bourdoulous S, Shimonaka M, Heinegard D, Schachner M, Ruoslahti E, Yamaguchi Y. 1997. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci USA 94:10116-10121.
4. Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A, Perris R. 2004. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18:779-781.
5. Fujimoto K, Nagafuchi A, Tsukita S, Kuraoka A, Ohokuma A, Shibata Y. 1997. Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J Cell Sci 110:311-322.
6. Harks EG, de Roos AD, Peters PH, de Haan LH, Brouwer A, Ypey DL, van Zoelen EJ, Theuvenet AP. 2001. Fenamates: A novel class of reversible gap junction blockers. J Pharmacol Exp Ther 298:1033-1041.
7. Ingber DE, Folkman J. 1989. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix. J Cell Biol 109:317-330.
8. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. 1995. Multiple forms of mouse PG-M. a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 270:958-965.
9. Jongen WM, Fitzgerald DJ, Asamoto M, Piccoli C, Slaga TJ, Gros D, Takeichi M, Yamasaki H. 1991. Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol 114:545-555.
10. Lampe PD, Lau AF. 2004. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36:1171-1186.
11. LeBaron RG, Zimmermann DR, Ruoslahti E. 1992. Hyaluronate binding properties of versican. J Biol Chem 267:10003-10010.
12. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. 1999. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1630-1639.
13. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, Watanabe H. 2003. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 278:41205-41212.
14. Miura R, Aspberg A, Ethell IM, Hagihara K, Schnaar RL, Ruoslahti E, Yamaguchi Y. 1999. The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J Biol Chem 274:11431-11438.
15. Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. 2003. Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem 278:30005-30014.
16. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. 2003. Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 83:1359-1400.
17. Saez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV. 2005. Connexin-based gap junction hemichannels: Gating mechanisms. Biochim Biophys Acta 1711:215-224.
18. Saito T, Schlegel R, Andresson T, Yuge L, Yamamoto M, Yamasaki H. 1998. Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells. Oncogene 17:1673-1680.
19. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G. 2003. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17:1355-1357.
20. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, Wu Y, Lee V, Slingerland J, Dumont D, Yang BB. 2005. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 16:1330-1340.
21. Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB. 2006. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 17:2009-2020.
22. Sullivan R, Lo CW. 1995. Expression of a connexin 43/beta-galactosidase fusion protein inhibits gap junctional communication in NIH3T3 cells. J Cell Biol 130:419-429.
23. Wu JC, Tsai RY, Chung TH. 2003. Role of catenins in the development of gap junctions in rat cardiomyocytes. J Cell Biochem 88:823-835.
24. Wu Y, Chen L, Cao L, Sheng W, Yang BB. 2004a. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and {beta}1-integrin. J Cell Sci 117:2227-2237.
25. Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, Wong CS, Lu WY, Yang BB. 2004b. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 15:2093-2104.
26. Wu Y, Wu J, Lee DY, Yee A, Cao L, Zhang Y, Klani C, Yang BB. 2005a. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol 24:3-13.
27. Wu YJ, Lapierre D, Wu J, Yee AJ, Yang BB. 2005b. The interaction of versican with its binding partners. Cell Res 15:483-494.
28. Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB, Lu WY. 2006. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 281:19358-19368.
29. Yamaguchi Y. 2000. Lecticans: Organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276-289.
30. Yang BL, Yang BB, Erwin M, Ang LC, Finkelstein J, Yee AJ. 2003. Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Life Sci 73:3399-3413.
31. Zako M, Shinomura T, Kimata K. 1997. Alternative splicing of the unique "PLUS" domain of chicken PG-M/versican is developmentally regulated. J Biol Chem 272:9325-9331.
32. Zheng PS, Vais D, Lapierre D, Liang YY, Lee V, Yang BL, Yang BB. 2004a. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci 117:5887-5895.
33. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB. 2004b. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18:754-756.
34. Zheng PS, Reis M, Sparling C, Lee DY, La Pierre DP, Wong CK, Deng Z, Kahai S, Wen J, Yang BB. 2006. Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1. J Biol Chem 281:8175-8182.